Showing results (1-10 of 387) with videos related to
Sort By:
Pageof 39
The Urologic Clinics of North America|May 9, 2007
Adjuvant chemotherapy for stage II nonseminomatous germ cell tumorsG Varuni Kondagunta, Robert J MotzerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Chemotherapy for advanced germ cell tumorsG Varuni Kondagunta, Robert J MotzerSeminars in Urologic Oncology|December 19, 2002
Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumorsG Varuni Kondagunta, Robert J MotzerSeminars in Oncology|July 19, 2003
Recommendations of follow-up after treatment of germ cell tumorsG Varuni Kondagunta, Joel Sheinfeld, Robert J MotzerUrology|September 19, 2006
Long-term response with sunitinib for metastatic renal cell carcinomaEllen A Ronnen, G Varuni Kondagunta, Michelle S Ginsberg, et al.The Journal of Urology|March 27, 2007
Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profilingJames E Korkola, G Varuni Kondagunta, Victor E Reuter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Dean Bajorin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Phase II trial of bortezomib for patients with advanced renal cell carcinomaG Varuni Kondagunta, Beverly Drucker, Lawrence Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Alessia Donadio, et al.Clinical Genitourinary Cancer|May 27, 2008
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinomaDarren R Feldman, G Varuni Kondagunta, Lawrence Schwartz, et al.Pageof 39